Rigel Pharmaceuticals Inc...

NASDAQ: RIGL · Real-Time Price · USD
39.55
1.66 (4.38%)
At close: Aug 15, 2025, 3:59 PM
39.51
-0.10%
After-hours: Aug 15, 2025, 07:58 PM EDT

Rigel Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
97.82M 37.18M 17.48M 3.88M -14.23M -19.8M -25.09M -24.43M -37.77M -44.66M -58.57M -82.61M -84.53M -84.86M -17.91M -14.51M -7.73M -11.49M
Depreciation & Amortization
2.43M 2.43M 2.23M 1.92M 1.6M 1.28M 1.24M 1.23M 1.18M 1.12M 998K 1.12M 1.14M 1.16M 1.16M 964K 868K 774K
Stock-Based Compensation
11.33M 10.58M 12.39M 12.24M 11.54M 11.18M 8.81M 10.95M 11.72M 11.94M 12.38M 10.64M 10.14M 10.05M 9.49M 8.78M 8.46M 7.91M
Other Working Capital
11.78M -1.31M 11.91M 1.01M -1.47M -4.29M -1.06M -3.39M -3.69M -4.02M -5.61M -576K 1.46M -56.89M 14.05M 22.16M 13.07M 70.21M
Other Non-Cash Items
-47.3M 12.06M 15.12M 15.08M 10.88M -1.62M -4.21M -3.69M -1.95M 50K 481K 1.16M 2.25M 3.79M 3.14M -3.47M -2.32M -1.82M
Deferred Income Tax
n/a n/a n/a -3.99M -2.18M n/a n/a 3.99M 2.18M n/a n/a 116K 192K 202K 287K 171K 131K 52K
Change in Working Capital
1.55M -16.18M -2.2M -8.83M -10.35M 1.35M 9.52M -9.47M -8.71M -20.64M -29.05M -1.36M 2.88M 69.85M 9.72M 17.46M 800K -64.47M
Operating Cash Flow
65.83M 35.59M 31.47M 10.73M -12.31M -6.68M -5.74M -21.41M -33.35M -52.2M -73.76M -70.94M -67.93M 196K 5.88M 9.39M 207K -69.05M
Capital Expenditures
324K 102K -36K -120K -492K -270K -15.13M -15.1M -15.26M -15.23M -450K -356K -337K -780K -627K -1.15M -1.18M -726K
Cash Acquisitions
n/a n/a n/a 110K 132K 132K 259K 149K 406K 670K 543K 522K 413K 556K 627K 1.15M 1.18M 770K
Purchase of Investments
-80.6M -49.13M -35.27M -30.55M -37.77M -39.01M -31.33M -21.19M -30.8M -22.29M -29.16M -50.7M -77.27M -144.16M -141.46M -135.11M -110.18M -72.65M
Sales Maturities Of Investments
39.6M 42.55M 39.7M 38.95M 41.2M 34.25M 41.65M 56.82M 77.98M 87.03M 101.23M 110.91M 82.89M 80M 62.05M 58.45M 97.47M 103.91M
Other Investing Acitivies
-262K 10.67M 10.98M 11.02M 11.37M 3.42M 3.23M 3.47M 3.73M 1.02M 23.75M 23.42M 22.97M 22.3M -627K -1.15M -1.18M -726K
Investing Cash Flow
-40.94M -6.74M 4.13M 8.17M 3.2M -4.76M -4.3M 21.18M 32.8M 50.92M 72.78M 60.67M 5.82M -64.94M -80.04M -77.81M -13.89M 30.54M
Debt Repayment
n/a n/a n/a n/a n/a n/a 19.95M 19.95M 29.55M 29.52M 19.54M 19.54M 9.94M 9.97M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-8.38M -8.64M -11.73M -12.71M -3.75M -3.37M -1.59M -4.17M -7.38M -13.24M -13.59M -10.41M -6.05M 59.4M 62.67M 62.26M 62.03M 13.33M
Financial Cash Flow
-7.47M -8.64M -11.64M -12.62M -3.65M -3.27M 18.37M 15.79M 22.16M 16.88M 6.55M 9.73M 4.49M 69.38M 62.67M 62.26M 62.03M 13.33M
Net Cash Flow
17.41M 20.21M 23.96M 6.28M -12.76M -14.71M 8.33M 15.55M 21.61M 15.61M 5.57M -537K -57.62M 4.63M -11.48M -6.16M 48.35M -25.18M
Free Cash Flow
66.15M 35.69M 31.43M 10.61M -12.8M -6.95M -20.88M -36.51M -48.62M -67.42M -74.21M -71.29M -68.27M -584K 5.25M 8.24M -970K -69.77M